Folic Acid Supplement Prevents Phenytoin-Induced Gingival Hyperplasia
Researchers at the Division of Pediatric Neurology, Neurosciences Centre, New Delhi, India, performed a randomized, double-blind, placebo-controlled 6-month trial of oral folic acid supplement (0.5 mg/day) in children aged 6-15 years treated with phenytoin for epilepsy.
Gespeichert in:
| 1. Verfasser: | |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Pediatric Neurology Briefs Publishers
2011-05-01
|
| Schriftenreihe: | Pediatric Neurology Briefs |
| Schlagworte: | |
| Online-Zugang: | https://www.pediatricneurologybriefs.com/articles/632 |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|